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Abstract
Introduction: In health services research, there is a special emphasis on the transition from adolescence into
adulthood. During this transition period, adolescents change from pediatric to adult medical care. This process must
be carefully structured, particularly when special medical care is required. Challenges and difficulties become
apparent particularly in the case of rare diseases. This is increasingly so when the rare disease affects the
adolescence-specific development of patients, such as Mayer-Rokitansky-Küster-Hauser syndrome (MRKHS), also
known as Müllerian agenesis.
Methods: A systematic literature review identified the care requirements of girls and young women with MRKHS,
as well as studies of medical care during the adolescent transition period for various other diseases. This
investigation was carried out in the years 2012 and 2013, and was updated in 2014/2015. In addition, the reference
lists of the identified studies were reviewed.
Results: Nine publications on MRKHS and ten publications on the transition from adolescence to adulthood were
included. Medical care requirements and measures were identified for the following areas: diagnosis during
adolescence and organization of medical care, reactions to the diagnosis, functional infertility, psychological stress
and threat to self-image, contact with others, and dealing with MRKHS coping strategies.
Discussion: There is still a great demand for research in the area of care during the transition period from
adolescence into adulthood, particularly for rare diseases. The recommendations for treating MRKHS patients
derived from the literature should be implemented and evaluated with regard to their effectiveness.
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Background
The transition from adolescence to adulthood – particu-
larly for adolescents with special medical needs – in-
cludes special requirements for treatment management
regarding disease-specific and phase-specific aspects [1].
“Transition is a multi-dimensional and multidisciplinary
process, which not only addresses the medical needs of
the adolescents when transitioning from pediatric to
adult care, but also includes psychosocial, scholastic, and
professional aspects” [1]. The term “transfer”, on the
other hand, describes a single aspect of the considerably
longer transition process – and here it means the direct
transfer from pediatric to adult medical care [1]. Both
terms are essential for understanding transition care.
The German Advisory Council on the Assessment of
Developments in the Healthcare System describes the
current state of transition care in Germany [1]:
– Due to a lack of coordination of the necessary
processes, patients run the risk of receiving
insufficient treatment during the transfer to adult
care. This insuffient care can lead adolecents to
discontinue therapy or to stop taking prescribed
medications.
– This lack of coordination means that transfers into
adult care are unplanned. There is no room for
coordinated support in the transition process.
– During adolescence, young patients not only have to
deal with a chronic disease, but also deal with
compelling questions regarding their sexuality,
leaving their childhood homes, and planning their
professional lives.
In Germany, initial steps are currently being taken to
improve transition management – see Berliner Transi-
tionsProgramm (BTP) (“Berlin Transition Program”) [2]
and the transition module “Erwachsen werden mit
ModuS: Fit für den Wechsel (“Coming of Age with
ModuS: Fit for the Change”) [3] – wherein data on the
effectiveness of these approaches must still be evaluated.
Previous approaches to transition management do not
put any special emphasis on rare diseases, although diffi-
culties in treatment management could become particu-
larly apparent in these cases. A disease is categorized as
“rare” when less than five to ten persons per 10,000 are
afflicted. One disease that represents a particular chal-
lenge with regard to transition management is Mayer-
Rokitansky-Küster-Hauser syndrome (MRKHS). The
prevalence of MRKHS is given as 1 in 5000 female births
[4]. This is characterized by the congenital absence of
the uterus and the upper 2/3 the vagina with a normal
46,XX karyotype and a normal, age-appropriate hor-
mone profile, since functional ovaries are present [4].
Therefore, the development of secondary sexual
characteristics occurs normally [4, 5] and thus the diag-
nosis MRKHS is generally made late, at the beginning of
puberty due to the lack of onset of menstruation (pri-
mary amenorhhea) or, seldom, due to the impossibility
of sexual intercourse [4]. On physical examination,
patients have normal breast development, normal sec-
ondary sexual body proportions, body hair, and hymenal
tissue [5], which is one of the reasons for misdiagnosis
up to 40 % at the first contact to a physician [6]. On the
other hand, this means, that these young women get
their diagnosis of “being not a complete women” in the
sensible phase of puberty. The presence of functioning
ovaries means patients are basically fertile; i.e. surrogacy
is possible; but the lack of a uterus means pregnancy
cannot be carried out by the patients themselves [4]. As
the vagina is either not developed or extremely short,
vaginal intercourse is seldom possible for women who
have not received treatment [4]. In approximately one
third to one half of all cases, patients have concomitant
congenital malformations, especially of the urinary tract
and skeleton [4, 7]. Therefore, evaluation for associated
congenital, renal, or other anomalies is also essential [8].
After the diagnosis, the patient should be offered
counseling to a specialiced center, which offers also psy-
chological counseling to emphasize that a normal sex life
will be possible after a neovagina has been created, espe-
cially as long-term results are very good [9] but also to
tell them how to deal with the problem of infertility,
wich comes up normally later, at the age of mid to late
twenties.
One of the goals to strengthen their self-empowerment
towards being a nomal woman is the creation of a neova-
gina, which looks like a normal one and where no use of
lubricans is needed.
Therefore, in our opinion, there are only two first line
treatment options
– The nonsurgical treatment: this means that patients
are asked to manually place successive dilators on
the perineal dimple for 30 min to 2 h per day.
Another option is sitting on a bicycle seat stool. The
bicycle seat stool provides the perineal pressure. Use
of dilators in the management of MRKHS is
appropriate and successful for mature, highly
motivated patients who wish to avoid surgery
because the treatment endures several months [5]
and is very painful and dilation of the uretra could
occure, It is no option, if the vaginal dimple is to
short.
– The surgical treatment should avoid big scars and
transplanted tissue like skin, bowl or peritoneum.
Therefore the laparoscopic-assisted creation of a
neovagina is the treatment of choice. This method
creates after a few months a neovagina by minimal
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invasive access with a normal epithelium after full
epithelialization [10, 11].
Apart from these treatment options infertility may be
a more difficult aspect for the patients to accept [5].
Purpose and methods
The past research focused mainly on physical aspects
and on evaluation of surgical methods. Other treatment
requirements of patients with MRKHS focusing on the
transition period are due to our knowledge discussed
less frequently. This systematic literature review aims to
determine treatment requirements of girls and young
women with MRKHS during transition and to develop
recommendations for the transition management of this
target group. The derived recommendations were devel-
oped in the context of health services research in
Germany.
The literature review was done within the framework
of the research project “TransCareO” [12, 13]. The sys-
tematic literature search was done using the PubMed
database from June 2012 to March 2013 (updated 2014/
2015). Detailed information on the search strategy and
selection process for inclusion in the study is described
in Fig. 1 and Table 1.
Results
A total of twelve studies [4, 7, 14–23] and seven theoret-
ical works [24–30] were included in the literature review
(Tables 2 and 3).
The studies were also evaluated with regard to their
internal validity using Stein's unbiased risk estimate
(SURE) criteria [31–33]. Care requirements for girls and
young women with MRKHS were extracted from exist-
ing literature. Similarly, based on the care requirements
identified, recommendations for treatment management
were derived for this disease. In the following, recom-
mendations will be presented for individual aspects of
treatment management.
Diagnosis during adolescence and organization of
medical care
MRKHS is commonly diagnosed in early to late adoles-
cence [24], when menarche fails to occur. For many
young women, the first menstrual period symbolizes
their female identity and maturity, and therefore
contributes significantly to identity formation [24]. At
the time of diagnosis, there is a risk that young women
will perceive themselves as fundamentally different from
their contemporaries [19, 24]. In addition, congnitive
immaturity, lack of experience, and “black-and-white
thinking” can lead to negative self-assessment and
Fig. 1 Study Extraction
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damaging coping strategies in dealing with the malfor-
mation [24]. Another problem at this sensitive age is
dealing with a disease that requires discussing intimate
topics, such as intercourse and sexuality, with other
people [14]. One study reports that adolescents in par-
ticular lack knowledge about this disease and its signifi-
cance [14]. In consequence, this can mean adolecents
are incapable of effectively participating in the decision-
making process regarding their own therapy, and there-
fore can lead to them developing the feeling that they
have no choice or control over planned treatment
methods [14]. In the publications analyzed, there is little
information on how medical care and treatment was ex-
perienced. One study reports that women with MRKHS
did not fully understand the medical terminology used
by their caregivers [14]. These patients experienced the
initial treatment period as a time of uncertainty [14].
Medical care was experienced as being limited to the
physical examination, which mainly dealt with the phys-
ical aspects of the malformation [14]. In this case the pa-
tients criticized the lack of information and
impersonality of provided care [14]. This led to patients
feeling isolated and insufficiently supported in dealing
with the disease and treatment [14]. Patterson et al. re-
ported that mothers of patients became more protective
of their daughters following diagnosis, took control, and
were the principal communicators with medical staff,
which is why patients did not see themselves as the main
focus of treatment [19]. They also reported that medical
personnel did not recognize or acknowledge the growing
autonomy of the young adults during the course of treat-
ment [19].
A recommendation for transition management can be
derived from this: young women should be informed
that, without treatment, there is little to no possibility of
sexual intercourse [4]. The type of communication and
the doctor-patient relationship are of particular import-
ance in this context. Young patients should always be
the focus of treatment and therapy, and should be
allowed to play an active roll in the decision-making
process [19]. It may also be desirable to conduct talks
with young patients without their parents present, to en-
able intimate aspects such as sexuality to be discussed
openly [19].
Reactions to the diagnosis
Patients report numerous emotions in reaction to their
diagnosis [24]. Positive reactions of relief as well as nega-
tive emotions were possible [24] – however, the negative
expressions appear to predominate. Examples described
in other studies include shock, confusion, fear, depres-
sion, suicidal thoughts, isolation, shame, guilt, and denial
[9, 24]. One review mentions feelings of loss and fear
[15]. In addition, as self-reported by some of the girls
and young women, the impact of the diagnosis was so
emotionally devastating that they were unable to fully
absorb or understand the information about therapy and
treatment given at that time [24].
It is therefore recommended that the emotional reac-
tions of the patients to the diagnoses be allowed for with
regard to further information about the disease and
treatment possibilities (information management), and
to repeat and explain important information at a later
point in time [24].
Table 1 Additional information about the inclusion process
Additional information about the inclusion process during the literature
research
• Identification Phase
To identify appropriate studies, a systematic literature search was carried
out using the PubMed database (online portal of the National Library of
Medicine) from June 2012 through March 2013. The literature search
was updated in 2014/2015 to include newer publications. The search
was carried out for clinical picture, target group, treatment
management, and outcome using keywords and keyword combinations
defined by the project team. The search was performed with a broad
scope, also including findings from publications on transition
management for other relevant diseases when deriving
recommendations. This was necessary, since few studies on transition
for rare diseases could be found in 2012 and 2013.
Two search strategies were applied:
- Search strategy 1 comprised a search for publications generally
related to the transition phase. The following keywords were used:
“young girl AND puberty AND disease course“ and “girl AND
transition“
- Search strategy 2 comprised searching for publications dealing
with the disease MRKHS in the context of transition. The following
catchwords were used: “parents AND MRKH“, “female AND
adolescent AND gential malformation AND MRKH”, “MRKH AND
transition“, “rokitans* AND organisation“, “female AND adolscent
AND gential malformation AND transition“, “female AND rokitans*
AND transfer”, “female AND adolscent (Mesh Terms) AND rokitans*
AND disease management AND quality of life”
The search in PubMed using both search strategies resulted in a total of
2,149 hits.
• Screening Phase
After excluding duplicates (n=365), all publications found in the search
were first evaluated according to title and abstract by two reviewers
from the project team, independently from one another, with regard to
suitability for the study question. This resulted in the exclusion of 1,615
hits. After a positive evaluation by both reviewers, the full-text was used
for further analysis.
• Full-text Analysis Phase
Following the screening phase, 166 hits were available for the full-text
analysis. The full texts were read by a third person who made the final
decision on inclusion in this review, and extracted the necessary content
from the publications. The reference lists of the full-text publications
read were also viewed for possible other suitable publications. In the
course of this process, an additional 154 hits were excluded (editorials,
descriptive publications, and therapy studies). Publications were
excluded that were not written in either German or in English. Studies
were also excluded if, due to the target group, the subject, or the
disease, there was no transferability to the situation of patients with
MRKHS.
• Integration Phase
A total of 12 publications were included from the full-text analysis and
an additional 7 publications from the reference lists of the included
publications were integrated into the literature review (4, 7, 14-30).
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Table 2 Studies on MRKHS





Examination of psychological effects and quality
of life following the diagnosis and treatment
of MRKHS





Examination of the effectiveness of group therapy
based on a cognitive behavior approach with
regard to the psychological outcome before
therapy, after therapy (7 weeks), and 3 months
after therapy in women with MRKHS
UK Intervention Group (n = 19) (response rate:
baseline 100 %, after treatment 84 %,
follow-up 84 %; age: 28.9, SD 10.0)
Control Group (n = 20) (response rate:
baseline 100 %, after treatment 80 %,
Follow-up 80 %; Alter: 27.6, SD 7.1)
Symptom Checklist (SCL-90-R)/Rosenberg
Self-Esteem Scale (RSE)/Impact of Events Scale




Cross-sectional study Examination of the psychological effect of MRKHS
when comparing women with MRKHS and healthy
women
UK 66 women (response rate: 20 %; age:
27.9, SD 1.0)
31 healthy women as a control group
(response rate: 73.8 %; age: 27.8, SD 1.5)
Symptom Checklist (SCL-90-R)/Rosenberg
Self-Esteem Scale (RSE)/Inventory of




Qualitative study Examination of personal experiences of women
with MRKHS, to gain insight into the psychological,
social, and emotional consequences of diagnosis
and treatment







Overview on the state of research on psychological
aspects of women with MRKHS
Germany 43 studies (differing methodologies) none
Loeser et al.
(2002)
Qualitative study Examination of mother-daughter relationships
throughout the course of peri- and postoperative
creation of a neovagina
Germany 8 women (response rate: no
information; age: 14–21)




Qualitative study Examination of the importance of MRKHS to gain
insight into social challenges during the transition
into adulthood







Evaluation of the effectiveness of group therapy
with regard to psychological burden before, at
the beginning, and after treatment of women
with MRKHS
Netherlands 17 women (for analysis: information
















Table 3 Studies on Transition
Authors Study Design Main Topic Country Numbers (Participants, Studies) Instruments Main Results
Castrejón (2012) Narrative literature
review
Overview of information available
in the literature on transition units
with regard to rheumatic diseases
USA 46 studies (differing
methodologies)
none Recommendations for interacting with adolescent patients
– Respect, confidentiality, avoiding mistakes, continuity,
autonomous visits without parents, use of the HEADSS
assessment
Components of a transition unit
– Early age, transition coordinator, transition program,
involvement of pediatricians and physicians for adults,
parents, multidisciplinarity , qualified personnel,
evaluation
Crowley et al. (2011) Systematic literature
review
Review of the efficacy of transition
programs in young patients
between the ages of 11 and 25
with chronic diseases or disabilities
and the identification of successful
components
UK 10 studies (Evaluation of
interventions during transition,
but with different methodology)
none Patients
– Disease-related education (4x successful intervention)
– Improved education and skills traning (2x successful
intervention)
Healthcare Facility
– Transition coordinator (2x successful intervention)
– Liaison between pediatric and adult hospital (3x
successful intervention)
Service offers
– Separate clinics for young adults (3x successful
intervention)
– Telephone support service (1x successful intervention)
– Appointment reminders by telephone (2x successful
intervention)
Forbes et al. (2002) Systematic literature
review
Identification and evaluation of
practices that assure adolecents
with chronic diseases and
disabilities of continuity during
the transition
UK Search A: 61 studies (Identification
of Best-Practice.models)
Search B: 39 studies (inclusion of
five diseases)
Search C: 26 studies (interview of
key persons)
none Structural component
– Transition worker; transition teams; professional
continuing education; information for specialists; use
of existing services; inter- and intra-organization of
networks and arrangements; organizational planing;
theoretical framework; promotion of equality and
accessibility.
Process components
– Preparation for the transfer; active management of
the transition; case management; responsibility for
the process; strengthening of therapeutic relationships;
representation of interests; joint care management;
flexibility with regard to the transfer; specific
communication systems; regular assessment of
provision of services.
Result components
– Disease-specific or general outcomes like satisfaction.
Other outcome components are benchmarks of how















Table 3 Studies on Transition (Continued)
Components of the practice regarding young people:
– Specific services provided; developing competence
in autonomy and self-determination; support for
psychosocial development; inclusion of young people;
peer Einbindung der junge Leute; involvement of
peers; support for the changed relationship with
parents/caregivers; making appropriate choices;
availability of information; concentration on young
people’s strengths for their future development
Components in practice regarding parents and caregivers:
– Support adjusting to the changed relationships to
the young people; inclusion of parents in work
scheduling; family-centered approach and provision
of information.
Price et al. (2011) Qualitative Study Evaluation of a transition model
based on interviews with young
adults with diabetes mellitus
UK 11 young adults (age: 16–18 years)






– The transition process
– Experience with, and organization of the transfer
– Organization of services




– appropriate health care of young people
















The infertility that is a consequence of the disease is dif-
ficult for women with MRKHS to accept [15]. Huber et
al. elaborate that this aspect of infertility, particularly
over time, influences the further well-being of women
with MRKHS [4].
It appears to be very important, therefore, to address
this aspect comprehensively with the patients and to in-
form them of alternative options (e.g. adoption) [15].
Psychological stress and threat to self-image
Three studies indicate that women with MRKHS tend to
have increased psychological stress [7, 16, 17]. In their
study, Heller-Boersma, Schmidt, and Edmonds [17]
show that women with MRKHS have significantly higher
values regarding risk to phobias and psycoticism than a
healthy control group, and show similar tendencies for
depression and fear. Furthermore, they report that in a
direct comparison with a healthy control group, women
with MRKHS have lower self-esteem [17]. MRKHS is
also commonly experienced as a threat to one’s own
identity and self-image [19, 24]. Due to the disease, role
models considered distinctly female are challenged [19].
On one hand, the body is perceived as a threat [24]; a
feeling that can increase when other malformations re-
lated to the disease are diagnosed [24]. On the other
hand, social and sexual roles are questionned [14, 17,
19]. Women with MRKHS can also feel a loss of a sense
of normality and belonging, in that they perceive them-
selves as being different than their peers [14]. This can
lead to negative self-image developing in women with
MRKHS, such as feeling different, defective or flawed,
sexually inadequate, worthless, unloveable, or not in
control [24]. There are also reports of feeling incom-
plete, for example when bearing children is considered
as a fundamental female role [19].
During treatment, the affected women should be of-
fered continuous guidance [24] and psychological sup-
port to cope with the diagnosis [19, 24]. Screening for
individual psychological stress in girls and young women
with MRKHS is also recommended [15].
Contact with others
Contact with others is challenging for women with
MRKHS. To some extent, the disease is experienced as a
social tabu [19]. Patients frequently have the strong de-
sire to keep the diagnosis secret [14, 19]. There are also
predominant worries about other people’s reactions;
both positive and negative reations were experienced
[14, 19]. In addition, it is shown that in their contact
with other people, it is sometimes impossible for women
with MRKHS to participate in certain conversations with
their peers [19]. There have also been occasional reports
of difficulties dealing with children or pregnant women
[19]. In particular, one study shows that women with
MRKHS do not feel understood by their social environ-
ments – they state that only other women with MRKHS
can understand their situation and experiences [19].
They express a strong desire to exchange feelings and
experiences directly with other patients of the same age
[19]. Another challenge is dealing with intimacy. Patients
find it difficult to find the right time to inform their
partners about their condition [19]. This is due, in part,
to fears that the relationship will be ended because of
the diagnosis and resulting effects on family planning
[19]. Another study examined the course of MRKHS
and individual mother-daughter relationships [18]. This
study showed that patients with a healthy relationship
with their mothers had fewer complications and better
coping strategies [18]. Parental support is seen as helpful
for a positive treatment outcome [15, 18].
Against this background, it is recommended that par-
ents be integrated into treatment planning and decision-
making [15]. Moreover, within the framework of the
healthcare system, establishing networks for similarly af-
fected girls and women is encouraged [19].
Dealing with MRKHS coping strategies
In general, dealing with MRKHS is extremely challen-
ging for patients. Due to the perceived threats repre-
sented by MRKHS, many patients implement potentially
damaging coping strategies, such as exaggerated femin-
ine appearance, poor choice of partners, addictive behav-
ior, etc. [24]. Bean et al. describe coping strategies that
range from complete denial of the disease to compensa-
tion through performance [15]. Moreover, some affected
women run the danger of perpetually comparing them-
selves to other women, resulting in a negative self-
assessment [24]. Dealing with MRKHS can also be influ-
enced by so-called triggers, or negative critical experi-
ences, that end up increasing their negative self-image
[24]. One example of this is when peers within the pa-
tients’ social environment start their own families [24].
Dealing with the disease can lead to avoidance behavior
and isolation, when women with MRKHS consciously
avoid certain situations, such as entering a sexual rela-
tionship, and instead focus on their careers [19]. How-
ever, one review reports that career choices do not vary
between women with MRKHS and healthy women [15].
Spirituality or religiousness are reported as another cop-
ing strategy to find meaning in the disease and therefore
the ability to cope with it [15].
Few recommendations with regard to coping strategies
have been made. As there is often a desire for inter-
action with other patients, self-help groups for girls and
young women appear helpful [19]. In two studies,
women with MRKHS were offered group therapy for
psychological support [7, 16]. The main result in both
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studies showed that the psychological stress due to
MRKHS could be significantly reduced [7, 16]. Programs
offering psychological support for women with MRKHS
appear to be effective.
Discussion
This paper examines care requirements and recommen-
dations for structuring health care during the transition
from adolescence to adulthood of girls and young
women with MRKHS. MRKHS is a rare disease, which
is diagnosed as a malformation of the female genitals
generally during adolecense, and thus during a phase in
which girls and young women are also grappling with
their female identities and engaging in their first sexual
contacts. This clearly shows the importance of gender-
sensitive psychosocial medical care during this transi-
tional period. Although there are some clinical studies
that examine somatic treatment possibilities and also
increasingly incorporate aspects of sexual medicine
(e.g. [34]), there are only few studies that address care
requirements and give recommendations for transition
management. Recommendations for the transition
management of young girls and women that can lead to
improvements could be distinguished in the literature.
They are particularly important amid clear findings that
improvements are needed in medical care and supervi-
sion within the framework of transition management.
Need for improvement was found particularly for com-
munication behavior, for information management, and
for psychological support designed and tailored specif-
ically to the target group [14, 19]. Other studies also
showed that early in the diagnostic process in >40 % of
the cases, false diagnoses were made, and even that in-
correct treatments were initiated [6, 35]. Specific
courses may be meaningful to train medical staff on
how to interact with these girls and young women, as
well as a transfer program specifically designed to ad-
dress this rare disease and to optimize care for this tar-
get group. However the infertility is difficult for women
with MRKHS to accept. In some countries there is the
possibility of surrogacy as an alternative method. In
Germany, it is not allowed. In recent years, new treat-
ment options haven been developed. Brännström et al.
described in the year 2014 the first clinical uterus trans-
plantation [36]. In the year 2015 they reported about a
successful livebirth after uterus transplantation [37].
Altough there exists new treatment options for patients
with MRKHS, it seems to be important to keep the in-
dividual care requirements of patients with MRKHS in
mind. The derived recommendations for treating
MRKHS patients during the transition period should be
implemented to optimize the medical care for this tar-
get group.
Limitations
This systematic literature review has some methodical
limitations. The literature review was carried out using
only one database. Therefore, there is a risk that relevant
studies on this subject were not considered and there-
fore not included in the review. A further breadth of
perspective was achieved, however, as the literature
search was expanded to include studies on the transition
management of other diseases. Therefore, the initial
focus on MRKHS may act as a “magnifying glass”,
through which challenges in transition management be-
come particularly evident, whereas simultaneously
expanding the literature search was able to avoid too
narrow of a perspective. This also provided for an in-
crease in the number of studies included. However, dis-
cussion is necessary concerning the extent to which
other rare diseases can be compared that have other
symptoms, greater prevalence, and more experience on
the part of medical staff. Another critical aspect from a
methodological perspective is that, for organizational
reasons, only one person (AW) carried out the full-text
analysis and the critical evaluation of the studies.
Conclusions
Altogether, the care requirements and recommendations
presented here are based on relatively few studies with
various study designs. It is clear that further studies are
necessary in order to support the recommendations
identified to improve transition management, and to sys-
tematically evaluate the effect of the interventions. This
is not only true for the treatment management of
MRKHS, but also in general for transition management
of many other rare diseases, for which systematic evalua-
tions are currently lacking [38].
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